Justin J. Ferayorni - May 20, 2021 Form 4 Insider Report for STREAMLINE HEALTH SOLUTIONS INC. (STRM)

Signature
/s/ Thomas J. Gibson, attorney-in-fact
Stock symbol
STRM
Transactions as of
May 20, 2021
Transactions value $
$75,000
Form type
4
Date filed
5/27/2021, 05:33 PM
Next filing
Jun 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STRM Common Stock, $0.01 par value Award $75K +37.5K +35.65% $2.00 143K May 20, 2021 Direct F3, F4
holding STRM Common Stock, $0.01 par value 4.93M May 20, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities represent 4,433,334 shares held directly by Tamarack Global Healthcare Fund, L.P. ("Fund 1") and 497,548 shares held directly by Tamarack Global Healthcare Fund QP, L.P. ("Fund 2"). Tamarack Capital Management, LLC is the general partner of Fund 1 and Fund 2, Tamarack Advisers, LP is the investment adviser to Fund 1 and Fund 2, and Justin J. Ferayorni is the sole managing member of both Tamarack Capital Management, LLC and Tamarack Capital GP, LLC. Tamarack Capital Management, LLC, Tamarack Advisers, LP, and Mr. Ferayorni may be deemed indirect beneficial owners of the shares held by Fund 1 and Fund 2 for purposes of Section 13(d) of the Securities Exchange Act of 1934 (the "Act").
F2 Tamarack Capital Management, LLC, Tamarack Advisers, LP, and Mr. Ferayorni disclaim beneficial ownership of any of the shares held by Fund 1 and Fund 2 for the purpose of determining whether they are subject to Section 16 of the Act, however, in reliance on Rule 16a-1(a)(1)(v) and (vii) under the Act. To the extent that they might be deemed subject to Section 16, they disclaim beneficial ownership of securities held by the Fund 1 and Fund 2 for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein, if any.
F3 Grant of restricted stock that vests in full on the earlier of (i) May 20, 2022 and (ii) the date of, and immediately prior to, the Company's 2022 annual meeting of stockholders.
F4 The reported securities represent shares owned directly by Mr. Ferayorni.

Remarks:

Mr. Ferayorni is the sole owner of the reported entities, other than Tamarack Global Healthcare Fund, L.P. and Tamarack Global Healthcare Fund QP, L.P., and signed this form on behalf of himself, each of the other reporting entities, and as the managing member of the general partner of Tamarack Global Healthcare Fund, L.P. and Tamarack Global Healthcare Fund QP, L.P.